Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 6/20 | 0.56 |
| ▸ | RAB9A | P51151 | 6/20 | 0.54 |
| ▸ | NPC1 | O15118 | 5/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.52 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.52 |
| ▸ | IGSF11 | Q5DX21 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13283028 | 0.89 | NPSR1 (0.55) | NPSR1RAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL13283020 | 0.85 | ALDH1A1 (0.66) | NPSR1RAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL13283023 | 0.84 | NPSR1 (0.61) | NPSR1RAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL13283027 | 0.82 | NPSR1 (0.53) | NPSR1RAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL13283021 | 0.82 | MAPT (0.63) | NPSR1RAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL13282910 | 0.82 | L3MBTL1 (0.55) | NPSR1RAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL13283029 | 0.82 | RAB9A (0.60) | NPSR1RAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL13282912 | 0.80 | L3MBTL1 (0.65) | NPSR1RAB9ANPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL13101622 | 0.78 | ALDH1A1 (0.67) | RAB9ANPC1ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL13102048 | 0.78 | ALDH1A1 (0.67) | RAB9ANPC1ALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190746-A1 | QUINAZOLINONES AS POTASSIUM CHANNEL MODULATORS | ICAGEN, INC. (US) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190746-A1 | QUINAZOLINONES AS POTASSIUM CHANNEL MODULATORS | KCNQ1, KCNK17, KCNQ2 | NPSR1 1722/4885RAB9A 560/4885NPC1 921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.